Improvement in Key PsA Core Domains With Guselkumab Treatment in an Enriched Population of ACR20 Non-responders at Week 24: Post Hoc Analysis of Two Phase 3 Studies

McGonagle, D., Haaland, D., Helliwell, P. orcid.org/0000-0002-4155-9105 et al. (6 more authors) (2023) Improvement in Key PsA Core Domains With Guselkumab Treatment in an Enriched Population of ACR20 Non-responders at Week 24: Post Hoc Analysis of Two Phase 3 Studies. [Conference abstract]

Metadata

Item Type: Conference abstract
Authors/Creators:
Keywords: American College of Rheumatology Criteria, Biologicals, clinical trial, Outcome measures, Psoriatic arthritis
Dates:
  • Published: 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Date Deposited: 01 Feb 2024 14:43
Last Modified: 05 Mar 2026 11:57
Published Version: https://acrabstracts.org/abstract/improvement-in-k...
Status: Published
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)